Selective Rather Than Routine Histopathological Examination Following

Status Completed

Clinical Trial Summary

The FANCY study will investigate whether a selective policy of histopathological examination of appendices and gallbladders based on the intraoperative findings of the surgeon is safe and cost-effective.

Clinical Trial Description

Traditionally, all surgically removed appendices and gallbladders are sent to the department of pathology for histopathological examination. This is most likely not necessary in appendices and gallbladders that are not suspicious for a tumour when inspected visually or by palpation. If not detected by visual inspection or palpation, the tumour is usually of early stage and already treated with the resection of the organ. A policy of selective histopathological examination based on the intraoperative findings of the surgeon can probably reduce the amount of appendices and gallbladders that have to be examined by the pathologist, without a risk of undertreatment, with less risk of overtreatment and huge savings annually. In the FANCY study, a nationwide prospective multicenter observational cohort study, all appendices and gallbladders will be evaluated for tumours by visual inspection and palpation by the operating surgeon. The operating surgeon will report his or her findings and also write down whether he or she thinks there is an indication for histopathological examination. Subsequently, all specimens are sent to the pathologist for histopathological examination. Therefore, no aberrant findings will be missed due to this study. The prospective cohort can be compared through modelling to a hypothetical situation where appendices and gallbladders are only examined by the pathologist on indication. The primary outcome is the number of patients per 1000 examined appendices/gallbladders with a neoplasm requiring additional therapy benefitting the patient that would have been unnoticed in the policy of selective histopathological examination. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03510923
Study type	Observational
Source	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact
Status	Completed
Phase
Start date	May 1, 2018
Completion date	December 24, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04852016` - Optimizing the Consent Process for Emergent Laparoscopic Cholecystectomy	N/A
Withdrawn	`NCT00979186` - A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance	N/A
Recruiting	`NCT06058195` - Comparison of Quadratus Lumborum and Transverse Abdominis Plane Blocks With Intravenous Analgesic in Gallbladder Surgery
Enrolling by invitation	`NCT02983474` - Korea Surgical Quality Improvement Program	N/A
Recruiting	`NCT05089526` - Opioid-free Anesthesia in Laparoscopic Cholecystectomies	N/A
Completed	`NCT04300985` - Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening.	Phase 3
Recruiting	`NCT03817541` - Expiratory and Plasma Propofol Concentration in Gastrological Surgery Patients	N/A
Completed	`NCT03577873` - RCT on Necessity of Cholecystectomy for Patients After Clearance of Bile Duct Stones	N/A
Completed	`NCT04270357` - Surgical Practices in Algeria : the Cholecystectomy
Completed	`NCT00689663` - Laparoscopic Cholecystectomy - Fundus First and Harmonic Ace Compared With Conventional Technique	N/A
Recruiting	`NCT06447545` - Comparison Between Low Pressure Pneumoperitoneum With High Pressure Pneumoperitoneum in Post-operative Pain, Shoulder Tip Pain and Common Bile Duct Injuries in Patients Undergoing Laparoscopic Cholecystectomy	N/A
Completed	`NCT03329859` - Microcomplications in Lap. Cholecystectomy: Reducing Intraoperative Interruptions by High Resolution Standardization	N/A
Terminated	`NCT02163239` - Post Market Study for FloShield 10mm Reusable Cannula and Blunt Obturator and Robotic FloShield	N/A
Completed	`NCT02085902` - Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?	Phase 4
Completed	`NCT06468735` - The Relationship Among Sarcopenia, Preperitoneal Fat Thickness and Cholecystectomy	N/A
Completed	`NCT05681338` - Effect of the Coughing Technique During Subcutaneous Heparin Injection	N/A
Completed	`NCT06020768` - The Effect of Different Bed-Head Angles on the Haemodynamic Parameters of Intensive Care Patients Lying in the Supine Position	N/A
Completed	`NCT01211743` - Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy	Phase 4
Completed	`NCT06028061` - Evaluation of Effectivity of Quadratus Lumborum Blocks With Adjuvant	N/A
Completed	`NCT05366907` - Open Cholecystectomy Among Patients Undergoing Laparoscopic Cholecystectomy.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy — FANCY

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms